Sintx Technologies, Inc. Total Long-Term Debt
Sintx Technologies, Inc. (SINT) had Total Long-Term Debt of $2.48 million as of 2018-06-30, per its 10-Q filed 2018-08-14.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2019-03-11
- 2018-06-30: Long-term Debt $2.48M.
- 2018-03-31: Long-term Debt $4.51M.
- 2017-12-31: Long-term Debt $2.96M.
- 2016-12-31: Long-term Debt $7.01M.
| Period end | Long-term Debt | Long-term Debt as first filed |
|---|---|---|
| 2018-06-30 | $2.48M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $4.51M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $2.96M 10-K · filed 2019-03-11 | |
| 2016-12-31 | $7.01M 10-K · filed 2018-03-29 | |
| 2016-09-30 | $8.43M 10-Q/A · filed 2017-12-27 | |
| 2016-06-30 | $11.15M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | $14.79M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $16.36M 10-Q/A · filed 2017-12-27 | $16.96M 10-K · filed 2016-03-23 |
| 2015-09-30 | $19.97M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $22.55M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $22.27M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $22.13M 10-K · filed 2016-03-23 | |
| 2014-09-30 | $22.70M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $20.12M 10-Q · filed 2014-08-08 | |
| 2013-12-31 | $17.93M 10-K · filed 2015-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B |